New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
Ineos has launched a major investment at Lavera to regenerate and modernize one of France’s most important industrial sites, safeguarding 10,000 jobs, with support from the French State.
Nouryon has opened a new innovation center in Shanghai to boost localized innovation, customer collaboration, and sustainable development in key industries across China and the Asia Pacific region.
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose packaging, and sterile filling.
Cambrex announced a $120 million investment to expand its API manufacturing capacity at its Charles City, Iowa, facility by 40%.
The investment will focus on developing gelatin and HPMC facilities, creating over 200 new jobs, and strengthening ACG’s 25-year presence in the US, with operations expected to begin in early 2027.
The Leeds Innovation & Application Center is the newest of the now 71 Brenntag Specialties innovation centers globally, 31 of which focus on Food & Nutrition.
Roquette has inaugurated a new Pharmaceutical Innovation Center in Brazil to support advanced research and development in the region’s pharmaceutical sector.
Clariant successfully completes its CHF 100 million investment in the Daya Bay plant in China, with the second production line becoming fully operational in November.
Polyvantis has opened a new Technology Center in Shanghai, China, to unite R&D, commercial, and manufacturing teams and accelerate innovation for optical and electrical film solutions.
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
Henkel has doubled the size of its South Dakota plant to increase production of thermal management materials for the electric vehicle and electronics markets.
Arkema has inaugurated a new laboratory in Normandy dedicated to dry coating processes for battery electrodes, aiming to advance sustainable manufacturing by reducing energy use and developing new battery solutions.
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.
BASF and cooperation partner GIG Karasek have celebrated the symbolic ground-breaking ceremony for one of the world's largest industrial heat pumps for CO2-free steam generation at the Ludwigshafen site.
Merck's first climate-neutral production facility has opened at its Blarney site in Cork, Ireland. The €150 million new building is part of the group's €440 million investment program in Ireland.
Solvay strengthens its competitiveness in Germany through portfolio realignment and investments.
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada.
New Bay Area building marks significant progress as part of Gilead's $32 billion US investment.
Honeywell’s Quantinuum has raised $600 million at a $10 billion valuation, with Nvidia and other key investors backing the company to accelerate development of advanced quantum technologies and global partnerships.
Vioneo awards ECI Group contract to build world’s first LDPE plant using entirely fossil-free feedstock.
The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D
CDMO Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts
With the start-up of its production unit in Kentucky, Arkema develops its low Global Warming Potential (GWP) fluorospecialties to meet demand for more sustainable solutions in building insulation and thermal management.
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).
Sumitomo Chemical has constructed and begun operation of a pilot facility at the Sodegaura site of its Chiba Works for its new proprietary process to produce propylene directly from ethanol.
Nouryon has signed a long-term agreement with Arauco for the supply of sodium chlorate and chlorine dioxide for Arauco's new $4.6 billion pulp mill in Mato Grosso do Sul, Brazil.
AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the US.
